Ambulatory Infusion Center

Listing Number: WE324-04003

The company was founded in 2005 by an infectious disease physician who has an established reputation for clinical excellence. They provide infusion therapy medications to patients in a safe, comfortable, and professional infusion center. The company has solid payor and referral relationships.

The Company receives referrals from various specialties such as Gastroenterology, Neurology and Rheumatology. There are several opportunities for strategic initiatives to significantly grow the business. Increased earnings with a synergistic/strategic partner.

Payor Mix: Insurance 75%, Medicare 25%, Private Pay 1%

Top Drugs/Products: 75% Biologics – TOP: Ilumya, Entyvio, Ocrevus, Remicade, Skyrizi, Cabenuva

Strategic Payor Contacts: Medicare, BC/BS of CA, CIGNA, UHC, Aetna

Advanced Diagnostic Imaging Center and Cardiology Practice

Listing Number: MA324-0033

This established cardiology practice, integrated with a state-of-the-art advanced imaging and diagnostics center, offers a unique opportunity for medical professionals or healthcare investors. Located in a prime area with a solid patient base, the practice is renowned for its comprehensive cardiovascular care and cutting-edge diagnostic capabilities.

Investing in this cardiology practice means acquiring a thriving business with a strong reputation, advanced diagnostic capabilities, and significant growth potential. It’s an ideal opportunity for a cardiologist looking to step into a well-established practice or an investor seeking a lucrative addition to their healthcare portfolio.

Financial Performance:

• 2024 YE Projected Revenue $ 4.1 MM
• Adjusted EBITDA exceeding $1.6MM
• Consistent revenue growth and profitability.
• Diverse payers mix with a significant percentage of insured patients.

Comprehensive Services:

• Full spectrum of cardiology services including diagnostics, imaging (ECHO, Carotid, etc.), treatment, and follow-up.
• Highly advanced sought after imaging modalities including Cardiac PET scanning

State-of-the-Art Facilities:

• Dedicated diagnostic center with the latest equipment and technology.
• Efficient workflow and patient management systems ensuring high patient satisfaction and retention.

Prime Location:

• Conveniently situated in high-traffic area with easy access to major Interstate linking three New England States.
• Strong referral network and partnerships with local hospitals and primary care providers.

Growth Potential:

• Opportunities to expand services and increase patient volume.
• Concierge Cardiology with subscription fee model to expand patient base and boost revenue
• 
  

Training and Transition Support: Worried about the transition process? Rest assured, the owners are committed to ensuring a seamless handover. From training and operational guidance to ongoing support during the transition period.

Diabetes Technology Products Provider

Listing Number: NE324-08010

This established business is the largest independent pharmacy in its market areas. The company provides insulin pumps, CGM (continuous glucose monitoring) products and disposable pump supplies.

Payor relationships include a direct contract with Medicaid and most managed Medicaid programs. This profitable company has developed proprietary opportunities for revenue and EBITDA growth. For FY 2023 the revenue was $8,077,766 with an adjusted EBITDA of $2,475,000.  The Company strategically exited unprofitable product lines in 2023 resulting in improved NOI in 2024.

Sleep Diagnostics and Supply

Listing Number: WE322-06065

The company manages sleep testing and treatment for hospital systems and correctional institutions. They offer clients an end-to-end solution to provide sleep testing from initial referral through delivery of test results to patients and providers. This includes staffing and equipment for the sleep lab and handling of all administrative duties related to completing the sleep study. 

For correctional customers the company also offers in-facility sleep apnea treatment solutions including CPAP machine and peripherals. Both correctional and hospital programs operate under master agreements in place with each customer or facility.

• Approximately 30 million Americans suffer from sleep apnea but 80% have not been diagnosed
• Recurring revenue due to contractual agreements with customers and strong backlog of patients needing testing
• Best in class margins and growing free cash flow
• Low customer concentration
• Little to no insurance reimbursement risk as customers pay the company directly for services provided
• Experienced management team with deep industry expertise

Listing Number: MA221-06005

Available for acquisition is this supplier of respiratory equipment and supplies to customers in home health, long term care and other healthcare facilities. The Company enjoys a strong reputation in the marketplace based on the integrity of their staff, individualized customer service and many years of experience and knowledge.

The Company has carved out a niche in the high-tech Respiratory market by sourcing and providing essentially needed supplies as well as specialty items. The company’s longevity in the industry has positioned it as one of the top companies in the state to support healthcare providers / clinicians providing respiratory & nursing services to their patients.

For the trailing twelve month period, the business generated sales in excess of $4.16MM.  This well-established company would be an excellent addition to a strategic buyer looking to expand into this geographic area, an add-on to their existing business or an entrepreneur interested in growing an established medical wholesale business.